Guidance

Antimicrobial intravenous-to-oral switch: criteria for early switch

The national antimicrobial intravenous-to-oral switch (IVOS) criteria for early switch​ contains 24 IVOS criteria categorised into 5 sections.

From:
UK Health Security Agency
Published
1 November 2022
Last updated
1 February 2023 — See all updates

Documents

National antimicrobial intravenous-to-oral switch (IVOS) criteria for early switch

HTML

Antimicrobial IVOS decision aid

PDF, 317 KB, 1 page

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@phe.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Antimicrobial IVOS decision aid: text alternative

HTML

Details

IVOS criteria were developed through collation of criteria from a sample of 45 acute hospital IVOS policies, completion of a rapid systematic literature review to validate selection of criteria, and a 4-step Delphi consensus-gathering process involving 279 multidisciplinary participants from all UK nations to agree evidence-based, UK-wide IVOS criteria for hospitalised adult patients.

This project has been led by the UK Health Security Agency (UKHSA)’s Healthcare-Associated Infection, Fungal, Antimicrobial Resistance, Antimicrobial Use and Sepsis Division, in collaboration with NHS England AMR Programme and UKHSA’s Behavioural Science and Insights Unit. 

Published 1 November 2022
Last updated 1 February 2023 + show all updates

  1. Added IVOS decision aid.

  2. First published.